Expert insights. Personalized for you.
Thus, it can be conveniently said that the Rare disease market, which was once barren land has now become fertile ground. First and foremost, the regulatory agencies were ready and willing, with ornaments in hand to decorate the Rare disease market with novel therapies. MORE
In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in France. That could signal a greater willingness to find solutions that can aid market access faced with cutting edge treatments. MORE
Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures. MORE
The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and what needs reform. In 2021 we might see the ripples from such policies come into the market. MORE
It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. MORE
2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. Proof will be in the pudding but health economics is primed to play a far bigger role in market access in 2021 in Spain. MORE
OPENING: Pharma companies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Digital marketing is becoming a valuable tool. The post Pharma’s move to digital Part 1 HCP Marketing appeared first on World of DTC Marketing.com. MORE
Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Italy. MORE
Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. The disconnect between consumers and prescription drug marketing has grown quite a bit. What about marketing to doctors? MORE
AstraZeneca has signed a deal with Chinese biotech, Junshi Biosciences, to market its cancer immunotherapy. Markets & Regulations MORE
5ive: The biggest obstacle, I have observed, to innovative pharma digital marketing is the lack of talent. They should be integrated fully with the brand especially when it comes to market research findings. As I See It Bad Pharma Digital marketing MORE
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. MORE
COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . MORE
You need to invest in digital marketing too. DTC marketers should be joined at the hip with their market research people. What I have found is that too many DTC marketers make mistakes by applying generic research to their product categories. When launching a new drug you should be getting weekly reach and awareness reports from your market research people. Marketing is not science; it’s an art. MORE
SGK Health’s digital marketing experts provide insights that can help build deeper, emotional connections with pharma consumers to amplify digital marketing strategies as marketers shift their focus toward consumer-centric marketing. MORE
With a new year comes the opportunity to think ahead for the market access landscape for the coming year. 2020 was a big year for market access initiatives in the UK, many of which are only just starting, and their impact will come through in 2021 and beyond. MORE
As of now, there is no cure for Rheumatoid Arthritis; however, medication and supportive treatments options are available in the market that can manage its progression. As per the Delveinsight, the total prevalent cases of Rheumatoid Arthritis in the seven major markets (i.e MORE
Hematopoietic stem cell transplantation is a curative option in the EPP treatment market, however, is not routinely done owing to safety concerns. Bone marrow transplantation has helped improve patient outcomes, however, the Erythropoietic protoporphyria market lacks a curative option. . MORE
Analysts at DelveInsight expect major changes in the Cystic Fibrosis market landscape in the foreseeable future. Some of the highlights from the ongoing transformation of the current market dynamics are as follows: Rapidly Growing Eligible Patient Pool. Promising Market Outlook. MORE
China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “China In-Vitro Diagnostics Market 2020-2024” report … Continue reading → Business Wire MORE
” While the sample is too small to make any immediate judgments it should be worrying to DTC marketers. Before COVID-19, the United States telehealth market was estimated at about $3 billion with 11% of consumers using telehealth in 2019. MORE
B2B marketers are preparing themselves for what lies ahead in 2021 after the fallout from the COVID-19 pandemic. . The widespread economic shutdown created a negative return on investment for marketers during the previous year. The Marketing Budget Plan. Email marketing . MORE
Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Antibody-Mediated Rejection – Market Insight, Epidemiology and Market Forecast 2030” drug pipelines has been … Continue reading → Business Wire MORE
OPENING : DTC marketers have relied too much on TV advertising. DTC marketers have relied too heavily on TV, and now new data shows that TV glory days are quickly fading and that people feel that commercials are repeated too frequently and are irrelevant to them. MORE
A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. MORE
PsyBio Therapeutics Announces Retention of Market Maker PsyBio Therapeutics Announces Retention of Market Maker TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt … Continue reading → GlobeNewswire MORE
United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares – ResearchAndMarkets.com United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares … Continue reading → Business Wire MORE
SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. Digital not only applies to DTC but to HCP marketing as well. MORE
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. DTC marketers need to be ready to understand and help patients who request new medications via telehealth or email. MORE
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too. MORE
However, the Chronic refractory cough market is dominated by off-label therapies. However, DelveInsight’s Chronic refractory cough market is majorly dominated by nonpharmacologic therapies, which include Speech Therapy and Physiotherapy. Cough! Cough! MORE
The Hypofibrinogenemia market requires curative treatment options, new diagnostics methodologies for easier identification of high-risk patients, and safer, standard, and effective replacement therapy. Articles Hypofibrinogenemia Hypofibrinogenemia Market rare blood diseases Rare Disease MORE
Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio LONDON–(BUSINESS WIRE)–#GlobalImmunohematologyMarket–The immunohematology market is poised to grow by USD 846.80 MORE
Marketing Related Topics 
World of DTC Marketing
OCTOBER 9, 2020
You need to invest in digital marketing too. DTC marketers should be joined at the hip with their market research people. What I have found is that too many DTC marketers make mistakes by applying generic research to their product categories. When launching a new drug you should be getting weekly reach and awareness reports from your market research people. Marketing is not science; it’s an art.
World of DTC Marketing
JANUARY 14, 2021
SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. Digital not only applies to DTC but to HCP marketing as well.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JULY 29, 2020
5ive: The biggest obstacle, I have observed, to innovative pharma digital marketing is the lack of talent. They should be integrated fully with the brand especially when it comes to market research findings. As I See It Bad Pharma Digital marketing
World of DTC Marketing
DECEMBER 3, 2020
Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. The disconnect between consumers and prescription drug marketing has grown quite a bit. What about marketing to doctors?
World of DTC Marketing
JANUARY 19, 2021
OPENING : DTC marketers have relied too much on TV advertising. DTC marketers have relied too heavily on TV, and now new data shows that TV glory days are quickly fading and that people feel that commercials are repeated too frequently and are irrelevant to them.
World of DTC Marketing
DECEMBER 2, 2020
” While the sample is too small to make any immediate judgments it should be worrying to DTC marketers. Before COVID-19, the United States telehealth market was estimated at about $3 billion with 11% of consumers using telehealth in 2019.
World of DTC Marketing
JANUARY 18, 2021
OPENING: Pharma companies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Digital marketing is becoming a valuable tool. The post Pharma’s move to digital Part 1 HCP Marketing appeared first on World of DTC Marketing.com.
World of DTC Marketing
MARCH 3, 2021
A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market.
Delveinsight
JANUARY 22, 2021
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.
Bio Pharma Dive
DECEMBER 18, 2020
How can pharma marketers overcome today's cost-constrained, competitive environment
Bio Pharma Dive
OCTOBER 7, 2020
Personalized, insight-driven omnichannel marketing has never been more beneficial or important
Bio Pharma Dive
JANUARY 19, 2021
With virtual interactions here to stay, it's important that pharma marketers continue to embrace the digital world. Learn how a personalized, insights-led approach to marketing drives results
Pharma Phorum
FEBRUARY 16, 2021
COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. .
Pharma Phorum
JANUARY 28, 2021
It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases.
Pharma Phorum
FEBRUARY 23, 2021
The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and what needs reform. In 2021 we might see the ripples from such policies come into the market.
World of DTC Marketing
JANUARY 4, 2021
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. DTC marketers need to be ready to understand and help patients who request new medications via telehealth or email.
World of DTC Marketing
AUGUST 9, 2020
Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures.
Pharma Phorum
MARCH 1, 2021
In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in France. That could signal a greater willingness to find solutions that can aid market access faced with cutting edge treatments.
Pharma Phorum
FEBRUARY 24, 2021
2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. Proof will be in the pudding but health economics is primed to play a far bigger role in market access in 2021 in Spain.
Pharma Phorum
JANUARY 12, 2021
With a new year comes the opportunity to think ahead for the market access landscape for the coming year. 2020 was a big year for market access initiatives in the UK, many of which are only just starting, and their impact will come through in 2021 and beyond.
BioPharma Reporter
MARCH 1, 2021
AstraZeneca has signed a deal with Chinese biotech, Junshi Biosciences, to market its cancer immunotherapy. Markets & Regulations
XTalks
FEBRUARY 2, 2021
B2B marketers are preparing themselves for what lies ahead in 2021 after the fallout from the COVID-19 pandemic. . The widespread economic shutdown created a negative return on investment for marketers during the previous year. The Marketing Budget Plan. Email marketing .
Delveinsight
FEBRUARY 22, 2021
Hematopoietic stem cell transplantation is a curative option in the EPP treatment market, however, is not routinely done owing to safety concerns. Bone marrow transplantation has helped improve patient outcomes, however, the Erythropoietic protoporphyria market lacks a curative option. .
Pharma Phorum
JANUARY 8, 2021
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.
Delveinsight
FEBRUARY 18, 2021
The Hypofibrinogenemia market requires curative treatment options, new diagnostics methodologies for easier identification of high-risk patients, and safer, standard, and effective replacement therapy. Articles Hypofibrinogenemia Hypofibrinogenemia Market rare blood diseases Rare Disease
BioTech 365
FEBRUARY 9, 2021
United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares – ResearchAndMarkets.com United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares … Continue reading → Business Wire
BioTech 365
DECEMBER 29, 2020
Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio LONDON–(BUSINESS WIRE)–#GlobalImmunohematologyMarket–The immunohematology market is poised to grow by USD 846.80
BioTech 365
MARCH 3, 2021
Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Antibody-Mediated Rejection – Market Insight, Epidemiology and Market Forecast 2030” drug pipelines has been … Continue reading → Business Wire
BioTech 365
FEBRUARY 15, 2021
Global Aromatherapy Market to Surpass US$ 8,763.3 Million by 2027, Says Coherent Market Insights (CMI) Global Aromatherapy Market to Surpass US$ 8,763.3
BioTech 365
MARCH 4, 2021
China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “China In-Vitro Diagnostics Market 2020-2024” report … Continue reading → Business Wire
Delveinsight
FEBRUARY 8, 2021
Analysts at DelveInsight expect major changes in the Cystic Fibrosis market landscape in the foreseeable future. Some of the highlights from the ongoing transformation of the current market dynamics are as follows: Rapidly Growing Eligible Patient Pool. Promising Market Outlook.
BioTech 365
FEBRUARY 10, 2021
Global Pyrazinamide Market to Surpass US$ 163.1 Mn by 2027, Says Coherent Market Insights (CMI) Global Pyrazinamide Market to Surpass US$ 163.1
Delveinsight
DECEMBER 2, 2020
As of now, there is no cure for Rheumatoid Arthritis; however, medication and supportive treatments options are available in the market that can manage its progression. As per the Delveinsight, the total prevalent cases of Rheumatoid Arthritis in the seven major markets (i.e
Pharma Phorum
FEBRUARY 1, 2021
Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Italy.
The Pharma Data
FEBRUARY 5, 2021
SGK Health’s digital marketing experts provide insights that can help build deeper, emotional connections with pharma consumers to amplify digital marketing strategies as marketers shift their focus toward consumer-centric marketing.
BioTech 365
MARCH 1, 2021
Global Ambulatory Infusion Center Market to Surpass US$ 51,244.7 Million by end of 2027, Says Coherent Market Insights (CMI) Global Ambulatory Infusion Center Market to Surpass US$ 51,244.7
BioTech 365
MARCH 1, 2021
Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic In Japan the “Rice Bran Oil” … Continue reading → Business Wire
Intouch Solutions
FEBRUARY 23, 2021
The post The Now and the Next: Advice for Pharma Marketers in the New Normal appeared first on Intouch Solutions. Blog Healthcare Marketing HCP Marketing Innovation Strategic Planning
Pharma Marketing Network
FEBRUARY 1, 2021
The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021. Featured Pharma Marketing Podcasts
BioTech 365
MARCH 4, 2021
PsyBio Therapeutics Announces Retention of Market Maker PsyBio Therapeutics Announces Retention of Market Maker TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt … Continue reading → GlobeNewswire
BioTech 365
FEBRUARY 3, 2021
Delveinsight
FEBRUARY 1, 2021
However, the Chronic refractory cough market is dominated by off-label therapies. However, DelveInsight’s Chronic refractory cough market is majorly dominated by nonpharmacologic therapies, which include Speech Therapy and Physiotherapy. Cough! Cough!
56 
Let's personalize your content